此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

da Vinci SP® 在结直肠手术中的研究性器械豁免研究

2026年9月10日 更新者:Intuitive Surgical

达芬奇 SP® 手术​​系统在结直肠良性和恶性疾病手术中的前瞻性、多中心研究

To confirm the safety and performance of the da Vinci SP Surgical System, Instruments and Accessories in a complex colorectal procedure such as low anterior resections or right colectomy.

研究概览

详细说明

Primary Performance:

  • The primary performance endpoint will be assessed as the ability to complete the planned da Vinci SP-assisted colorectal procedure without conversion to an alternate approach. Conversion* to an alternate approach comprises conversion to open, multiport laparoscopic**, multiport robotic or hand-assisted§ approach requiring undocking of the da Vinci SP Surgical System in order to complete the planned procedure using the alternate approach.

    • Performing an extracorporeal anastomosis is not considered a conversion ** Use of additional assistant laparoscopic port(s) is not considered a conversion § Laparoscopic or robotic with hand assistance

Primary Safety:

• The primary safety endpoint will be assessed as the incidence of all intraoperative and post-operative adverse events that occur through the 42-day follow-up period

研究类型

介入性

注册 (实际的)

60

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Florida
      • Orlando、Florida、美国、32803
        • Adventist Health System/Sunbelt
    • Michigan
      • Detroit、Michigan、美国、48202
        • Henry Ford
    • Minnesota
      • Rochester、Minnesota、美国、55905
        • Mayo Clinic
    • Nevada
      • Las Vegas、Nevada、美国、89128
        • MountianView Hospital
    • Pennsylvania
      • Pittsburgh、Pennsylvania、美国、15212
        • Allegheny General Hospital
    • Texas
      • Houston、Texas、美国、77030
        • Houston Methodist Research Institute
    • Washington
      • Tacoma、Washington、美国、98405
        • MultiCare - Tacoma
    • Dong-gu
      • Ulsan、Dong-gu、韩国、25 Daehakbyeongwon-ro
        • Ulsan University Hospital
    • Gangseo-gu
      • Seoul、Gangseo-gu、韩国、Gonghang-daero
        • Ewha Womans University College of Medicine

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Age ≥ 18 years
  • BMI ≤ 35
  • Candidate for single-port robotic-assisted surgery for low anterior resection with or without total mesorectal excision or right colectomy procedures
  • ASA ≤ 3
  • Willing and able to provide a written informed consent document
  • Willing and able to comply with the study protocol requirements including perioperative follow-up examinations at 14 days, 42 days post operatively, and post-market long-term follow-up on an annual basis through 5 years

Exclusion Criteria:

  • Clinical or radiological evidence of metastatic disease
  • Life expectancy less than 6 months
  • Cancer of the anal canal requiring an abdominoperineal resection
  • Subjects with threatened mesorectal margins (≤1 mm) on MRI or ultrasound (for LAR ONLY)
  • Subjects with planned major concomitant procedures (eg. hepatectomaies, other intestinal resections) or emergent case
  • Subjects undergoing both LAR/TME and right colectomy during the same operation
  • Preoperative colonoscopy demonstrating synchronous colorectal cancer
  • History of inflammatory bowel disease
  • Subject has a known bleeding or clotting disorder
  • Uncontrolled illness including, but not limited to ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
  • Subject is contraindicated for general anesthesia or surgery
  • Subject had prior incisional hernia with mesh repair
  • Subject belongs to vulnerable population
  • Subject is pregnant or suspected to be pregnant

Intraoperative Exclusion Criteria:

• Subject presents with adhesions or scarring in the pelvis which in the opinion of the investigator limits the ability to perform the minimally invasive procedure

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:其他
  • 分配:非随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
其他:SP Lower Anterior Resection

Lower anterior resections (LAR) procedures will performed by da Vinci SP® Surgical System

da Vinci SP Surgical System, instruments, and accessories in complex colorectal procedures such as low anterior resection procedure or right colectomy with or without total mesorectal excision

其他:SP Right Colectomy

Right Colectomy (RC) procedures performed by da Vinci SP® Surgical System

da Vinci SP Surgical System, instruments, and accessories in complex colorectal procedures such as low anterior resection procedure or right colectomy with or without total mesorectal excision

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Rate of Conversion
大体时间:IntraOperative period

Performance defined as ability to complete the planned da Vinci SP-assisted colorectal procedure without conversion to an alternate approach.

IntraOperative period
Major Adverse Events Rates
大体时间:Intraoperative through the 42-day postoperative period

Safety defined as the incidence of all major adverse events that occur through the 42-day follow-up period

Intraoperative through the 42-day postoperative period

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 研究主任:Madhu L Gorrepati、Clinical Affairs Director

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2021年6月3日

初级完成 (实际的)

2023年9月30日

研究完成 (估计的)

2028年11月30日

研究注册日期

首次提交

2020年5月14日

首先提交符合 QC 标准的

2020年5月21日

首次发布 (实际的)

2020年5月27日

研究记录更新

最后更新发布 (实际的)

2026年10月1日

上次提交的符合 QC 标准的更新

2026年9月10日

最后验证

2026年5月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

是的

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅